United Community Bank’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-142
Closed -$5.22K 562
2026
Q1
$5.22K Buy
+142
New +$6.73K ﹤0.01% 484
2025
Q4
Sell
-154
Closed -$8.54K 619
2025
Q3
$8.54K Buy
154
+108
+235% +$6.32K ﹤0.01% 477
2025
Q2
$3.17K Buy
+46
New +$3.13K ﹤0.01% 470

Other funds holding NVO

United Community Bank's NVO Position: Q2 2026 in Review

United Community Bank sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 142 shares — an estimated $5.22K sold.

United Community Bank first reported a position in NVO in Q2 2025 and held it in 3 quarters. The position peaked at $8.54K in Q3 2025. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • United Community Bank reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • United Community Bank sold 142 Novo Nordisk shares in Q2 2026, an estimated $5.22K.
  • United Community Bank first reported a position in Novo Nordisk in Q2 2025 and held it in 3 quarters.
  • United Community Bank's Novo Nordisk position peaked at $8.54K in Q3 2025.
  • 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on United Community Bank's 13F filing for Q2 2026, filed 13 Aug 2026.